Y. Reilly

Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.

P. Chanda, M. Minchin, A. Davis, 1993, Molecular pharmacology.

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.

Y. Reilly, J. Haskins, G. Dover, 1993, European journal of pharmacology.

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.

I A Cliffe, Y. Reilly, G. Dover, 1995, European journal of pharmacology.

(S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.

Y. Reilly, C. Routledge, A. Fletcher, 1993, Journal of medicinal chemistry.

Characterisation of the Binding of [3H]WAY‐100635, a Novel 5‐Hydroxytryptamine1A Receptor Antagonist, to Rat Brain

M. Minchin, Y. Reilly, X. Khawaja, 1995, Journal of neurochemistry.